• Investing Ideas
  • /
  • Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies
Header cover image

Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED Apr 26, 2024

Companies with a Value score of at least 3, ordered by Value score

63 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

CMPS N

COMPASS Pathways		US$171.680%n/aUS$562.8mUS$859.96PB2.5xE32.5%n/a

ITCI *

Intra-Cellular Therapies		US$1,251.41n/a10.2%US$7.8bUS$1,566.32PS16.5xE57.6%n/a

ALNY *

Alnylam Pharmaceuticals		US$2,453.000%-33.7%US$18.1bUS$3,763.15PS9.9xE60.6%n/a

GXI N

Gerresheimer		€1,649.750%n/a€3.6b€2,073.48PE31.3xE19.7%1.2%

CRL *

Charles River Laboratories International		US$4,048.971.0%n/aUS$12.3bUS$4,810.79PE24.6xE11.4%n/a

ABBV *

AbbVie		US$2,743.00-2.7%1.4%US$282.6bUS$3,147.33PE47.5xE24.2%3.9%

4528 N

Ono Pharmaceutical		JP¥341.690%-34.5%JP¥1.3tJP¥352.56PE10.2xE-5.2%3.0%

BMRN *

BioMarin Pharmaceutical		US$1,557.87-0.008%n/aUS$17.3bUS$2,080.64PE75.9xE29.8%n/a

ATOS *

Atossa Therapeutics		US$25.5010.9%113.4%US$191.7mUS$76.39PB2.1xE66.0%n/a

NVS N

Novartis		CHF1,540.010%n/aCHF182.6bCHF1,706.18PE21.9xE10.0%3.7%

VRTX *

Vertex Pharmaceuticals		US$6,825.001.1%10.8%US$102.7bUS$7,893.74PE28.4xE11.5%n/a

HCM N

HUTCHMED (China)		UK£819.630%0%UK£1.6bUK£1,868.97PS4.7xE53.8%n/a

ABCM N

Abcam		US$292.380%-2.5%US$3.7bUS$360.48PS8.1xE37.2%0%

GSK N

GSK		UK£655.000%n/aUK£67.5bUK£794.79PE13.7xE9.3%3.5%

IQV *

IQVIA Holdings		US$3,925.000%17.9%US$42.8bUS$4,601.85PE31.5xE12.9%0%
Page 3 of 3
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.